TR199902839A3 - Yeni 4-ikameli piperidinler. - Google Patents

Yeni 4-ikameli piperidinler.

Info

Publication number
TR199902839A3
TR199902839A3 TR1999/02839A TR9902839A TR199902839A3 TR 199902839 A3 TR199902839 A3 TR 199902839A3 TR 1999/02839 A TR1999/02839 A TR 1999/02839A TR 9902839 A TR9902839 A TR 9902839A TR 199902839 A3 TR199902839 A3 TR 199902839A3
Authority
TR
Turkey
Prior art keywords
new
substituted piperidines
piperidines
substituted
Prior art date
Application number
TR1999/02839A
Other languages
English (en)
Other versions
TR199902839A2 (tr
Inventor
Orjales Venero Aurelio
Toledo Avello Antonio
Pumar Duran Carmen
Original Assignee
Faes Fabrica Espa Ola De Productos Quimicos Y Farmaceuticos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Fabrica Espa Ola De Productos Quimicos Y Farmaceuticos filed Critical Faes Fabrica Espa Ola De Productos Quimicos Y Farmaceuticos
Publication of TR199902839A3 publication Critical patent/TR199902839A3/tr
Publication of TR199902839A2 publication Critical patent/TR199902839A2/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR1999/02839A 1998-11-18 1999-11-17 Yeni 4-ikameli piperidinler. TR199902839A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009802420A ES2157148B1 (es) 1998-11-18 1998-11-18 Nuevas piperidinas 4-sustituidas.

Publications (2)

Publication Number Publication Date
TR199902839A3 true TR199902839A3 (tr) 2000-09-21
TR199902839A2 TR199902839A2 (tr) 2000-09-21

Family

ID=8305832

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02839A TR199902839A2 (tr) 1998-11-18 1999-11-17 Yeni 4-ikameli piperidinler.

Country Status (21)

Country Link
EP (1) EP1002794B1 (tr)
JP (1) JP4667552B2 (tr)
KR (1) KR100646675B1 (tr)
AR (1) AR028805A1 (tr)
AT (1) ATE422199T1 (tr)
AU (1) AU757177B2 (tr)
BR (1) BR9905634B1 (tr)
CA (1) CA2288533C (tr)
CY (1) CY1108955T1 (tr)
CZ (1) CZ296053B6 (tr)
DE (1) DE69940378D1 (tr)
DK (1) DK1002794T3 (tr)
ES (2) ES2157148B1 (tr)
HR (1) HRP990354B1 (tr)
HU (1) HU227558B1 (tr)
IL (1) IL132862A0 (tr)
NO (1) NO314401B1 (tr)
PL (1) PL196329B1 (tr)
PT (1) PT1002794E (tr)
RU (1) RU2232753C2 (tr)
TR (1) TR199902839A2 (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003101443A1 (en) * 2002-05-30 2003-12-11 Head Explorer A/S The use of milnacipran for the treatment of tension-type headache
UA77536C2 (en) * 2002-07-03 2006-12-15 Lundbeck & Co As H Secondary aminoaniline piperidines as mch1 antagonists and their use
EP1735302B1 (en) 2004-02-27 2010-06-16 Eli Lilly And Company 4-amino-piperidine derivatives as monoamine uptake inhibitors
CN1968932A (zh) 2004-06-18 2007-05-23 惠氏公司 制备6-烷基-5-芳基磺酰基-二氢菲啶的方法
EP1854785A1 (en) * 2006-05-12 2007-11-14 Faes Farma, S.A. 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
CN101506164A (zh) * 2006-08-23 2009-08-12 辉瑞产品公司 哌啶衍生物
DK2358674T3 (da) * 2008-11-14 2013-04-08 Theravance Inc Fremgangsmåde til fremstilling af 4-[2-(2-fluorphenoxymethyl)phenyl]piperidinforbindelser
WO2010120910A1 (en) * 2009-04-15 2010-10-21 Theravance, Inc. 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
WO2011147780A1 (en) 2010-05-24 2011-12-01 Faes Farma, S.A. Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
EP2390248A1 (en) 2010-05-24 2011-11-30 Faes Farma, S.A. Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203149A (en) * 1968-06-10 1970-08-26 Ici Ltd Piperidine derivatives
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
JPH0840999A (ja) * 1994-08-04 1996-02-13 Yamanouchi Pharmaceut Co Ltd フルオロインダン誘導体
CO5150201A1 (es) * 1998-09-07 2002-04-29 Hoffmann La Roche Derivados de piperidina

Also Published As

Publication number Publication date
BR9905634B1 (pt) 2012-09-04
EP1002794B1 (en) 2009-02-04
HU227558B1 (en) 2011-08-29
NO995643L (no) 2000-05-19
ATE422199T1 (de) 2009-02-15
IL132862A0 (en) 2001-03-19
EP1002794A1 (en) 2000-05-24
PT1002794E (pt) 2009-03-25
JP2000154176A (ja) 2000-06-06
AU757177B2 (en) 2003-02-06
CA2288533C (en) 2009-01-06
KR20000035525A (ko) 2000-06-26
HRP990354B1 (en) 2008-11-30
DE69940378D1 (de) 2009-03-19
ES2157148A1 (es) 2001-08-01
PL196329B1 (pl) 2007-12-31
ES2157148B1 (es) 2002-03-01
CY1108955T1 (el) 2014-07-02
HUP9904086A2 (hu) 2000-11-28
CA2288533A1 (en) 2000-05-18
AR028805A1 (es) 2003-05-28
TR199902839A2 (tr) 2000-09-21
PL336607A1 (en) 2000-05-22
NO314401B1 (no) 2003-03-17
NO995643D0 (no) 1999-11-17
KR100646675B1 (ko) 2006-11-17
BR9905634A (pt) 2000-09-26
ES2323742T3 (es) 2009-07-23
RU2232753C2 (ru) 2004-07-20
DK1002794T3 (da) 2009-04-14
CZ399599A3 (cs) 2000-08-16
HUP9904086A3 (en) 2001-11-28
CZ296053B6 (cs) 2005-12-14
JP4667552B2 (ja) 2011-04-13
HRP990354A2 (en) 2000-06-30
HU9904086D0 (en) 2000-01-28
AU5936699A (en) 2000-05-25

Similar Documents

Publication Publication Date Title
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
CU23049A3 (es) Dihidropirimidinas.
DE60000003T2 (de) Paroxetinmethansulfonat
DZ2934A1 (fr) Nouveaux composés de pipérazine et de pipéridine.
IT1309578B1 (it) Composizione fotoinduribile pigmentata.
ID26909A (id) Turunan-turunan 1,3,4-oksadiazolon
TR199902839A3 (tr) Yeni 4-ikameli piperidinler.
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
NO20020597D0 (no) 1,4-substituerte 4,4-diaryl cykloheksaner
ID27686A (id) Turunan 3-(2-okso-[1,3]bipirolidinil-3-ildenametil)-sefem
DK1149106T3 (da) 4,5-azolo-oxindoler
ID26368A (id) Turunan-turunan 2 deoksi higromisin
DE59909590D1 (de) Azidfreie, gaserzeugende zusammensetzung
TR200001621A3 (tr) Yeni arilpiperazinilalkil-3(2H)-Piridaziononlar
ATE272624T1 (de) Substituierte 4-(3-alkenyl-benzoyl)-pyrazole
ES1039413Y (es) Nueva ficha-deportista.
DK1037892T3 (da) Piperidinderivater
ES1039126Y (es) Bisagra.
ES1040336Y (es) Lingote mejorado.
ES1039730Y (es) Rodapie.
ES1040343Y (es) Carrito portafregona.
ES1040589Y (es) Expositor-dispensador.
ES1040633Y (es) Escalifono.
ES1042117Y (es) Mesa-sombrilla.
ES1040731Y (es) Gafa.